UT

Utah Medical Products IncNASDAQ UTMD Stock Report

Last reporting period 30 Jun, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

0.232

Micro

Exchange

XNAS - Nasdaq

UTMD Stock Analysis

UT

Attractive

Based on Eyestock quantitative analysis, UTMD`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

102/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

44.3 %

Greatly undervalued

Market cap $B

0.232

Dividend yield

1.76 %

Shares outstanding

3.628 B

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah. UTMD’s products include Blood Monitoring, which includes Deltran Disposable Blood Pressure Transducers, Deltran Plus Arterial Blood Sampling Systems, and Deltran Accessories; Electrosurgery, which includes Epitome Electrosurgical Scalpels, OptiMicro Ultra-Fine Tip Electrosurgical Needles, Finesse+ Electrosurgical Generators, Filtresse Surgical Smoke Evacuation Systems and Finesse+ Accessories; Labor and Delivery, which includes AROM-Cot, BT-Cath, CVX-Ripe, Intran, Muc-X and Cordguard; Neonatal Intensive Care, which includes Hemo-Nate, Thora-Cath, Nutri-Cath, Nutri-Lok, Myelo-Nate, Disposa-Hood, Neonatal Deltran, Pala-Nate, PICC-Nate, Dialy-Nate, Umbili-Cath and Uri-Cath; Urological Care, which includes the Liberty, Supra-Foley, and Pathfinder Plus; Womens Pelvic Health, and original equipment manufacturer/Capabilities.

View Section: Eyestock Rating